Tuesday, 21 December 2010

ERT announces the appointment of Joel Morganroth MD as interim CEO

ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today confirmed that the effective date of the previously announced retirement of Dr Michael J McKelvey, its President and CEO, is December 21, 2010.

Dr Joel Morganroth (pictured), currently ERT's Chairman and Chief Scientific Officer, has also been elected by the Board as President and CEO until ERT hires a permanent CEO. Dr Morganroth has served as the Chairman of ERT's Board of Directors since 1999 and as Chief Scientific Officer since April 2006. He previously served as the company's Chief Executive Officer from 1993 to March 2001 and also has consulted for ERT since 1977. Dr Morganroth is also a globally recognized cardiologist and clinical researcher and has had more than 10 years' experience as a medical review officer/expert for the US Food and Drug Administration (FDA).

Dr Morganroth commented: "We thank Dr McKelvey for his years of service and wish him well in his future endeavors."